2016冷泉港亞洲會議-肝病和肝癌：從基礎研究到臨床應用
肝病和肝癌：從基礎研究到臨床應用
4月25-29日 | 蘇州獨墅湖會議酒店
http://www.csh-asia.org/2016meetings/Liver.html
http://www.csh-asia.org/2016meetings/Liver.html
科學組委會成員:
馮根生, 美國加州大學圣迭戈分校
王紅陽, 中國東方肝膽外科醫院/研究所
Jessica Zucman-Rossi, 法國全國保健和醫學研究院
會議主題：
1. Liver progenitor cells and tumor-initiating cells
2. Liver injuries, fibrosis and cirrhosis
3. Alcoholic and non-alcoholic fatty liver diseases
4. Translational and clinical studies of liver cancer
5. Genomics and bioinformatics of liver diseases
6. Liver metabolism and metabolic disorders
7. Hepatic inflammation and immunity
1. Liver progenitor cells and tumor-initiating cells
2. Liver injuries, fibrosis and cirrhosis
3. Alcoholic and non-alcoholic fatty liver diseases
4. Translational and clinical studies of liver cancer
5. Genomics and bioinformatics of liver diseases
6. Liver metabolism and metabolic disorders
7. Hepatic inflammation and immunity
主題演講嘉賓:
Scott Lowe, Memorial Sloan Kettering Cancer Center/HHMI, USA
Abstract title: Tumor Suppressor & Tumor Maintenance Genes
Inder Verma, The Salk Institute, USA
Abstract title: Tumor Suppressor & Tumor Maintenance Genes
Inder Verma, The Salk Institute, USA
特邀演講嘉賓:
David Brenner, University of California, San Diego, USA
Abstract title: Genetics of liver fibrosis
David Cohen, Brigham and Women's Hospital, USA
Abstract title: Acyl-CoA Thioesterase-Mediated Metabolic Regulation
Sabine Colnot, Institut Cochin, INSERM U1016, FRANCE
Abstract title: Metabolic Reprogramming in Beta-Catemin-Driven Liver Carcinogenesis in Mice
Chantal Desdouets, INSERM U567, FRANCE
Abstract title: Liver polyploidy: Dr Jekyll or Mr Hide?
Gen-Sheng Feng, University of California, San Diego, USA
Abstract title: Cooperating or opposing roles of Pten and Shp2 in hepatocarcinogenesis or leukemogenesis
Eithan Galun, Hadassah Hebrew University Hospital, ISRAEL
Abstract title: Mir 122 is a hepatic-hormone with systemic effects
Ping Gao, University of Science & Techonology of China, CHINA
Abstract title: The regulation of metabolic reprogramming in hepatocellular carcinoma cells
Mathias Heikenwälder, Technische Universitat Munchen, GERMANY
Abstract title: Identification of novel targets to treat NASH and its transition to HCC
Lijian Hui, Institute of Biochemistry and Cell Biology, SIBS, CAS, CHINA
Sophie Lotersztajn, Center for Research on Inflammation, Inserm, France
Shelly Lu, Cedars-Sinai Medical Center, USA
Abstract title: Role of Methionine Adenosyltransferase 1A in Liver Cancer
Tom Lüdde, University Hospital RWTH Aachen, GERMANY
Abstract title: Programmed cell death pathways in liver injury and hepatocarcinogenesis
Atsushi Miyajima, University of Tokyo, JAPAN
Abstract title: Remodeling of the biliary tree during liver regeneration
Kanaga Sabapathy, National Cancer Centre Singapore, SINGAPORE
Robert Schwabe, Columbia University, USA
Young-Joon Surh, Seoul National University, SOUTH KOREA
Hongyang Wang, Eastern Hepatobiliary Hospital/Institute of Shanghai, CHINA
Xiao-Fan Wang, Duke University School of Medicine, USA
Abstract title: Inflammation-dependent IL-18 signaling restricts hepatocellular carcinoma growth by systematic modulation of lymphocyte activity
Xin Wei Wang, National Institute of Health, USA
Abstract title: Integrated Omics Investigation of Tumor Heterogeneity and Drivers in Liver Cancer
Holger Willenbring, University of California San Francisco, USA
Abstract title: Hepatocyte plasticity in liver regeneration and cancer
Lars Zender, University Hospital Tuebingen, Germany
Jessica Zucman-Rossi, INSERM U674, FRANCE
Abstract title: Genetics of liver fibrosis
David Cohen, Brigham and Women's Hospital, USA
Abstract title: Acyl-CoA Thioesterase-Mediated Metabolic Regulation
Sabine Colnot, Institut Cochin, INSERM U1016, FRANCE
Abstract title: Metabolic Reprogramming in Beta-Catemin-Driven Liver Carcinogenesis in Mice
Chantal Desdouets, INSERM U567, FRANCE
Abstract title: Liver polyploidy: Dr Jekyll or Mr Hide?
Gen-Sheng Feng, University of California, San Diego, USA
Abstract title: Cooperating or opposing roles of Pten and Shp2 in hepatocarcinogenesis or leukemogenesis
Eithan Galun, Hadassah Hebrew University Hospital, ISRAEL
Abstract title: Mir 122 is a hepatic-hormone with systemic effects
Ping Gao, University of Science & Techonology of China, CHINA
Abstract title: The regulation of metabolic reprogramming in hepatocellular carcinoma cells
Mathias Heikenwälder, Technische Universitat Munchen, GERMANY
Abstract title: Identification of novel targets to treat NASH and its transition to HCC
Lijian Hui, Institute of Biochemistry and Cell Biology, SIBS, CAS, CHINA
Sophie Lotersztajn, Center for Research on Inflammation, Inserm, France
Shelly Lu, Cedars-Sinai Medical Center, USA
Abstract title: Role of Methionine Adenosyltransferase 1A in Liver Cancer
Tom Lüdde, University Hospital RWTH Aachen, GERMANY
Abstract title: Programmed cell death pathways in liver injury and hepatocarcinogenesis
Atsushi Miyajima, University of Tokyo, JAPAN
Abstract title: Remodeling of the biliary tree during liver regeneration
Kanaga Sabapathy, National Cancer Centre Singapore, SINGAPORE
Robert Schwabe, Columbia University, USA
Young-Joon Surh, Seoul National University, SOUTH KOREA
Hongyang Wang, Eastern Hepatobiliary Hospital/Institute of Shanghai, CHINA
Xiao-Fan Wang, Duke University School of Medicine, USA
Abstract title: Inflammation-dependent IL-18 signaling restricts hepatocellular carcinoma growth by systematic modulation of lymphocyte activity
Xin Wei Wang, National Institute of Health, USA
Abstract title: Integrated Omics Investigation of Tumor Heterogeneity and Drivers in Liver Cancer
Holger Willenbring, University of California San Francisco, USA
Abstract title: Hepatocyte plasticity in liver regeneration and cancer
Lars Zender, University Hospital Tuebingen, Germany
Jessica Zucman-Rossi, INSERM U674, FRANCE
|
|
聯系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029-1301 Fax: +86-512-62729028 Email: mikeji@csh-asia.org Website: www.csh-asia.org |
- 因美納邀您參加CSCO第九屆血液腫瘤學術大會
- 千奧星科精彩亮相2025神經科學技術研討會
- 諾達思攜多款產品亮相2025中國人類工效學學術會議
- 美森與您相約CMC-CHINA第七屆中國制藥工業博覽會
- CPHI&PMEC 2025制藥工業展（深圳）通知
- 2026第三十三屆成都醫療健康博覽會邀請函
- NGDx2025中國先進診斷技術開發與應用論壇議程表
- 關于征集藥食同源及藥膳配方食品標準試點單位的通知
- 關于征集藥食同源優選產品評價規范參編單位的通知
- QD中國攜單細胞方案亮相國際干細胞研究學會年會
- 維拓啟創助力2025表面肌電論壇在杭成功召開
- 易科泰應邀參加動物遺傳專業委員會2025年學術年會
- 奧偉登攜前沿顯微技術亮相廈門2025中國材料大會
- CIIDC 2025中國（成都）儀器創新發展大會通知
- 2025新疆（昌吉）農業展覽會即將震撼啟幕
- 因美納邀您參加CSCO第九屆血液腫瘤學術大會
- NGDx2025中國先進診斷技術開發與應用論壇議程表
- 10x Chromium GEM-X動物及畜牧類研究獎勵計劃啟動
- Vizgen攜森西賽智亮相空間生物國際會議分享空轉進展
- 怡美通德正式成為PacBio中國區授權代理商
- 相約BioCon2025，因美納邀您共話腫瘤精準醫學新篇章
- 怡美通德邀您共赴單細胞及空間轉錄蛋白多組學論壇
- 10x Genomics技術方案更新(5月)，新手冊邀您下載
- 10x新品發布網絡研討會:Visium HD 3’空間分析方案
- Oxford Nanopore明日直播：納米孔測序大會亞太專場
- 10x邀您報名Visium和Xenium數據分析研討會(北京場)
- 第三屆中國國際生殖醫學健康大會（北京站）通知
- 10x Genomics技術方案更新(4月)，新手冊邀您領取
- 10x邀您參加單細胞與空間多組學前沿峰會-北京站
- 真邁FASTASeq 300 Dx獲批NMPA三類醫療器械注冊證
Copyright(C) 1998-2025 生物器材網 電話：021-64166852;13621656896 E-mail：info@bio-equip.com